PLoS Biology (Sep 2023)

The transcription factor DUX4 orchestrates translational reprogramming by broadly suppressing translation efficiency and promoting expression of DUX4-induced mRNAs.

  • Danielle C Hamm,
  • Ellen M Paatela,
  • Sean R Bennett,
  • Chao-Jen Wong,
  • Amy E Campbell,
  • Cynthia L Wladyka,
  • Andrew A Smith,
  • Sujatha Jagannathan,
  • Andrew C Hsieh,
  • Stephen J Tapscott

DOI
https://doi.org/10.1371/journal.pbio.3002317
Journal volume & issue
Vol. 21, no. 9
p. e3002317

Abstract

Read online

Translational control is critical for cell fate transitions during development, lineage specification, and tumorigenesis. Here, we show that the transcription factor double homeobox protein 4 (DUX4), and its previously characterized transcriptional program, broadly regulates translation to change the cellular proteome. DUX4 is a key regulator of zygotic genome activation in human embryos, whereas misexpression of DUX4 causes facioscapulohumeral muscular dystrophy (FSHD) and is associated with MHC-I suppression and immune evasion in cancer. We report that translation initiation and elongation factors are disrupted downstream of DUX4 expression in human myoblasts. Genome-wide translation profiling identified mRNAs susceptible to DUX4-induced translation inhibition, including those encoding antigen presentation factors and muscle lineage proteins, while DUX4-induced mRNAs were robustly translated. Endogenous expression of DUX4 in human FSHD myotubes and cancer cell lines also correlated with reduced protein synthesis and MHC-I presentation. Our findings reveal that DUX4 orchestrates cell state conversion by suppressing the cellular proteome while maintaining translation of DUX4-induced mRNAs to promote an early developmental program.